Post-earnings recap
Reported
Wed, Jul 29, 2026
EPS actual
$1.13
EPS est.
$1.04
EPS surprise
+8.86%
1-day move
+12.15%
GE HealthCare Technologies Inc. reported better-than-expected earnings per share, which likely contributed to a strong stock reaction, with shares rising by 12.15%. The absence of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the earnings beat, but more information would be needed to assess the company's trajectory.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.13 | N/A | +8.86% |
| Revenue | N/A | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±3.5%
GE HealthCare Technologies Inc. operates in the health care sector, focusing on medical equipment and technology. As a leader in this industry, the company plays a crucial role in advancing healthcare solutions, particularly in imaging and monitoring technologies, which are essential for patient care and diagnostics.
Last quarter
In Q1 2026, GE HealthCare reported an EPS of $0.99, falling short of expectations by 7%. Following the announcement, the stock dropped by 13.16%, indicating investor disappointment.
Management promises and guidance
EPS beat streak
1Q
EPS beat rate
88%
Avg EPS surprise
+6.86%
Avg 1-day reaction
+0.99%
Overall, Wall Street is cautiously optimistic about GE HealthCare's upcoming earnings. Investors are keen to see if the company can rebound from its recent earnings miss and provide positive guidance.
Bull case
If GE HealthCare can exceed EPS expectations and demonstrate strong revenue growth, it may signal a recovery and renewed investor confidence, potentially leading to a stock price increase.
Bear case
Conversely, if the company misses EPS expectations again or fails to provide a clear growth strategy, it could lead to further declines in stock price, reflecting ongoing concerns about its performance.
Key metrics to watch
Earnings Per Share (EPS)
$1.06EPS is a key indicator of the company's profitability and is closely watched by investors.
Revenue Growth
N/ARevenue growth reflects the company's ability to expand its market presence and increase sales, which is vital for long-term success.
The print will turn on these.
Q1
Will GE HealthCare achieve an EPS of at least $1.06?
This figure is critical as it will determine if the company can regain investor confidence after the last quarter's miss.
Q2
What specific growth strategies will management outline for the imaging equipment segment?
Investors are looking for clarity on how the company plans to navigate competitive pressures and expand its market share.
Why consensus could be wrong
The Street may be underestimating the potential for a rebound in imaging equipment demand, particularly in emerging markets where GE HealthCare has been expanding.
Supporting evidence
The company's historical EPS beat rate of 88% suggests a strong likelihood of exceeding expectations.
Options pricing indicates a significant potential move, reflecting uncertainty that may not align with actual performance.
Recent investments in innovation could lead to improved product offerings that drive sales.
Key risk
If the imaging equipment segment shows unexpected growth, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is crucial as it follows a disappointing earnings report, and the market is eager to see if the company can turn things around.
Bull confirmed if
An EPS of $1.06 or higher, along with positive commentary on revenue growth in imaging technology.
Bear confirmed if
An EPS below $0.99, indicating continued struggles in profitability.
What the market is pricing for the move.
Implied Move
±16.12%
Historical Avg
±6.9%
The options market is pricing in a significant potential movement in the stock price, indicating heightened uncertainty ahead of the earnings report.
Options are pricing ±16.1% while GEHC has averaged ±6.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
49.8%
Smart-money positioning from the most recent 13F filings.
Institutional
94.00%
of float
Insider
0.37%
of float
Holders
1,686
institutions
Top Holders· as of Jun 2026
Dodge & Cox Inc.
37,864,164 sh · $2.4B
8.38%
20.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If GE HealthCare beats EPS expectations, history suggests the stock could rise by around 1.61%, confirming a positive turnaround narrative.
In line / cautious
If results are in line with expectations, the stock may remain relatively stable, but cautious commentary could lead to volatility.
Miss
If the company misses expectations again, history suggests a potential drop of around 13.16%, reinforcing negative sentiment.
The lines on the call that would change the story.
Market Share in Imaging Equipment
N/AUnderstanding market share helps gauge competitive positioning and growth potential within the healthcare equipment sector.
Blackrock Inc.
37,467,843 sh · $2.4B
8.30%
4.1%
Vanguard Capital Management LLC
29,724,359 sh · $1.9B
6.58%
3.0%
State Street Corporation
20,861,566 sh · $1.3B
4.62%
1.6%
Vanguard Portfolio Management LLC
20,275,526 sh · $1.3B
4.49%
5.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.